Stock Events

Stock Events

Diasorin S.p.A. 

$92.00
120
+$0.00+0%Monday 18:02

Statistics

Day High
92
Day Low
92
52W High
92
52W Low
66.5
Volume
226
Avg. Volume
9
Mkt Cap
5.15B
P/E Ratio
25.75
Dividend Yield
1.64%
Dividend
1.51

Upcoming

Dividends

1.64%Dividend Yield
May 2026
$1.51
May 2025
$1.36
May 2024
$1.25
May 2023
$1.18
May 2022
$1.12
10Y Growth
7.59%
5Y Growth
4.39%
3Y Growth
8.49%
1Y Growth
11.13%

Earnings

Jul 31Expected
Q4 2023
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
0
0.68
1.35
2.03
Expected EPS
N/A
Actual EPS
N/A

Financials

12.95%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
1.38BRevenue
178.11MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DSRLF. It's not an investment recommendation.
Intesa Sanpaolo Spa
16
ISP.MI
Enel Spa
14
ENEL.MI
Unicredit Spa
13
UCG.MI
Pfizer
12
PFE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a major player in diagnostics and pharmaceuticals, directly competing with Diasorin in the diagnostics and testing market.
Abbott Laboratories
ABT
Mkt Cap190.39B
Abbott Laboratories offers a wide range of diagnostics equipment and tests, including for infectious diseases, competing in the same space as Diasorin.
Danaher
DHR
Mkt Cap161.86B
Danaher Corporation owns several companies in the diagnostics sector, including Cepheid and Beckman Coulter, making it a direct competitor.
Thermo Fisher Scientific
TMO
Mkt Cap257.42B
Thermo Fisher Scientific provides a broad array of diagnostics and research products, competing with Diasorin in the life sciences and diagnostics fields.
Bio-Rad Laboratories
BIO
Mkt Cap10.26B
Bio-Rad Laboratories, Inc. offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components, competing in diagnostics.
Qiagen NV
QGEN
Mkt Cap10.39B
Qiagen N.V. is known for sample and assay technologies for molecular diagnostics, applying competitive pressure in the diagnostics market.
Becton Dickinson
BDX
Mkt Cap57.71B
Becton, Dickinson and Company is a global medical technology company that offers diagnostic products and equipment, competing across several of Diasorin’s market segments.
Bruker
BRKR
Mkt Cap9.36B
Bruker Corporation offers scientific instruments and analytical and diagnostic solutions, competing in the advanced diagnostics field alongside Diasorin.

About

DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, gastrointestinal diseases, hepatitis and retroviruses, endocrinology, metabolic disorders, tumor markers, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay. Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.
Show More
CEO
Carlo Rosa
Employees
3260
Country
Italy
ISIN
IT0003492391
WKN
000A0MTB2

Listings

OTC Link
US
DSRLF
STU
DE
34D.STU
MU
DE
34D.MU
LSE
GB
0GZX.LSE

0 Comments

Share your thoughts

FAQs

What is Diasorin S.p.A. stock price today?▼
The current price of DSRLF is $92.00 USD — it has increased by +0% in the past 24 hours. Watch Diasorin S.p.A. stock price performance more closely on the chart.
What is Diasorin S.p.A. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Diasorin S.p.A. stocks are traded under the ticker DSRLF.
Is Diasorin S.p.A. stock price growing?▼
DSRLF stock has risen by +0% compared to the previous week, the month change is a +9.37% rise, over the last year Diasorin S.p.A. has showed a +28.38% increase.
What is Diasorin S.p.A. market cap?▼
Today Diasorin S.p.A. has the market capitalization of 5.15B
When is the next Diasorin S.p.A. earnings date?▼
Diasorin S.p.A. is going to release the next earnings report on March 12, 2027.
What is Diasorin S.p.A. revenue for the last year?▼
Diasorin S.p.A. revenue for the last year amounts to 1.38B USD.
What is Diasorin S.p.A. net income for the last year?▼
DSRLF net income for the last year is 178.11M USD.
Does Diasorin S.p.A. pay dividends?▼
Yes, DSRLF dividends are paid annual. The last dividend per share was 1.51 . As of today, Dividend Yield (FWD)% is 1.64%.
How many employees does Diasorin S.p.A. have?▼
As of November 11, 2026, the company has 3,260 employees.
In which sector is Diasorin S.p.A. located?▼
Diasorin S.p.A. operates in the Health & Wellness sector.
When did Diasorin S.p.A. complete a stock split?▼
Diasorin S.p.A. has not had any recent stock splits.
Where is Diasorin S.p.A. headquartered?▼
Diasorin S.p.A. is headquartered in Saluggia, Italy.